These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39209000)

  • 21. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
    Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α-Lactalbumin Peptide Asp-Gln-Trp Ameliorates Hepatic Steatosis and Oxidative Stress in Free Fatty Acids-Treated HepG2 Cells and High-Fat Diet-Induced NAFLD Mice by Activating the PPARα Pathway.
    Chen H; Ma Y; Qi X; Tian J; Ma Y; Niu T
    Mol Nutr Food Res; 2023 Aug; 67(16):e2200499. PubMed ID: 37354055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
    Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
    J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
    Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
    Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice.
    Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH
    Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD.
    Yang S; Cao SJ; Li CY; Zhang Q; Zhang BL; Qiu F; Kang N
    J Ethnopharmacol; 2024 Oct; 332():118354. PubMed ID: 38762210
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Bae S; Lee YH; Lee J; Park J; Jun W
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558538
    [No Abstract]   [Full Text] [Related]  

  • 31. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis.
    Bechmann LP; Vetter D; Ishida J; Hannivoort RA; Lang UE; Kocabayoglu P; Fiel MI; Muñoz U; Patman GL; Ge F; Yakar S; Li X; Agius L; Lee YM; Zhang W; Hui KY; Televantou D; Schwartz GJ; LeRoith D; Berk PD; Nagai R; Suzuki T; Reeves HL; Friedman SL
    J Hepatol; 2013 May; 58(5):1000-6. PubMed ID: 23353867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1.
    Ziamajidi N; Khaghani S; Hassanzadeh G; Vardasbi S; Ahmadian S; Nowrouzi A; Ghaffari SM; Abdirad A
    Food Chem Toxicol; 2013 Aug; 58():198-209. PubMed ID: 23603006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tetrahydrocurcumin ameliorates hepatic steatosis by restoring hepatocytes lipophagy through mTORC1-TFEB pathway in nonalcoholic steatohepatitis.
    Wu J; Guan F; Huang H; Chen H; Liu Y; Zhang S; Li M; Chen J
    Biomed Pharmacother; 2024 Sep; 178():117297. PubMed ID: 39137653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ursodesoxycholic acid is an FFA4 agonist and reduces hepatic steatosis via FFA4 signaling.
    Xu F; Wang J; Wang P; Hou T; Zhou H; Zhao Y; Wang J; Liu Y; Liang X
    Eur J Pharmacol; 2022 Feb; 917():174760. PubMed ID: 35033554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt.
    Jia Y; Wu C; Kim J; Kim B; Lee SJ
    J Nutr Biochem; 2016 Feb; 28():9-18. PubMed ID: 26878778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
    Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W
    Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
    Bian Y; Li X; Li X; Ju J; Liang H; Hu X; Dong L; Wang N; Li J; Zhang Y; Yang B
    Biomed Pharmacother; 2019 Sep; 117():109176. PubMed ID: 31387185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
    Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
    Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
    Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
    Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.